Psilocybin and Body Changes :: Chemistry Chemical Drugs Papers

psilocin and Body ChangesPhysiological (Whole Body) Changes Psilocybin, the active psychotomimetic, hallucinogenic chemical found in the psilocybe genus of mushrooms, is absorbed through the mouth and stomach and is a monoamine-related substance (Levitt 1975, Grilly, 1998). This meat that psilocins biochemical personal effects ar mediated by changes in the military action of serotonin, dopamine, and norepinephrine in the central nervous system (made up of the promontory and the spinal cord) primarily by way of 5HT2a receptors (Grilly 1998, Hasler 2003). Monoamine-related drugs share a canonic similarity in molecular structure with monoamine neurotransmitters serotonin, dopamine, and norepinephrine. Psilocybin produces bodily changes which are mostly sympathomimetic. This means that psilocybin mimics the effects of stimulating postganglionic sympathomimetic sympathetic nerves (online medical). The effects of this sympathetic nervous system stimulus may consist of pu pillary dilation, increases in blood pressure and lovingness rate, exaggeration of deep tendon reflexes, tremor, nausea, piloerection (hair erection), and increased body temperature (Grilly 1998). Psilocybin creates discrete psychological (hallucinogenic, entheogenic) changes in humans. Because of the mind-altering properties of the drug, much research on psilocybin is devoted to understanding its physiological effects on oral sex chemistry. A recent study tested prefrontal activation during a cognitive challenge and the neurometabolic effects of four different drugs on 113 components of interest of the brain (Gouzoulis 1999). The four substances tested were psilocybin, d-methamphetamine (METH), methylenedioxyethylamphetamine (MDE), and a placebo in healthy volunteers. No earthshaking differences of global cerebral metabolism were found in the four groups. Neurometabolic effects were found to include a significant increase of regional glucose operation in the the right way anterior cingulate of the brain, the right frontal operculum, and an increase in activity of the right inferior temporal region. A significant slack in metabolism was found in the right thalamus, the leave precentral region and a decrease in activity was found in the left thalamus. Overall there was a general hypermetabolism of the prefrontal region of the right hemisphere and hypometabolism in subcortical regions. During the cognitive challenge activation of the halfway prefrontal cortex was eliminated and activation of Brocas area (right frontal operculum) was reduced. In a study conducted by A.M. Quetin, electrolyte levels, liver toxicity tests and blood sugar levels were shown to be